Registro:

Referencias:

• Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics (2011) CA Cancer J Clin, 61, p. 134
• Schulz, W.A., Burchardt, M., Cronauer, M.V., Molecular biology of prostate cancer (2003) Mol Hum Reprod, 9, pp. 437-448
• Bickers, B., Aukim-Hastie, C., New molecular biomarkers for the prognosis and management of prostate cancer - The post PSA era (2009) Anticancer Res, 29, pp. 3289-3298
• Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674
• Truman, J.P., Rotenberg, S.A., Kang, J.H., Lerman, G., Fuks, Z., Kolesnick, R., Marquez, V.E., Haimovitz-Friedman, A., PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo (2009) Cancer Biol Ther, 8, pp. 54-63
• Fan, R., Kumaravel, T.S., Jalali, F., Marrano, P., Squire, J.A., Bristow, R.G., Defective DNA strand break repair after DNA damage in prostate cancer cells: Implications for genetic instability and prostate cancer progression (2004) Cancer Res, 64, pp. 8526-8533
• Navone, N.M., Troncoso, P., Pisters, L.L., Goodrow, T.L., Palmer, J.L., Nichols, W.W., Von Eschenbach, A.C., Conti, C.J., P53 protein accumulation and gene mutation in the progression of human prostate carcinoma (1993) J Natl Cancer Inst, 85, pp. 1657-1669
• Barbazetto, I.A., Room, M., Yannuzzi, N.A., Barile, G.R., Merriam, J.E., Bardal, A.M., Freund, K.B., Allikmets, R., ATM gene variants in patients with idiopathic perifoveal telangiectasia (2008) Invest Ophthalmol Vis Sci, 49, pp. 3806-3811
• Taylor, A.M., Metcalfe, J.A., Thick, J., Mak, Y.F., Leukemia and lymphoma in ataxia telangiectasia (1996) Blood, 87, pp. 423-438
• Swift, M., Reitnauer, P.J., Morrell, D., Chase, C.L., Breast and other cancers in families with ataxia-telangiectasia (1987) N Engl J Med, 316, pp. 1289-1294
• Berkovich, E., Ginsberg, D., ATM is a target for positive regulation by E2F-1 (2003) Oncogene, 22, pp. 161-167
• Keating, K.E., Gueven, N., Watters, D., Rodemann, H.P., Lavin, M.F., Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein (2001) Oncogene, 20, pp. 4281-4290
• Deng, C.X., BRCA1: Cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution (2006) Nucleic Acids Res, 34, pp. 1416-1426
• Rosen, E.M., Fan, S., Ma, Y., BRCA1 regulation of transcription (2006) Cancer Lett, 236, pp. 175-185
• Mullan, P.B., Quinn, J.E., Harkin, D.P., The role of BRCA1 in transcriptional regulation and cell cycle control (2006) Oncogene, 25, pp. 5854-5863
• Di, L.J., Fernandez, A.G., De Siervi, A., Longo, D.L., Gardner, K., Transcriptional regulation of BRCA1 expression by a metabolic switch (2010) Nat Struct Mol Biol, 17, pp. 1406-1413
• De Siervi, A., De Luca, P., Byun, J.S., Di, L.J., Fufa, T., Haggerty, C.M., Vazquez, E., Gardner, K., Transcriptional autoregulation by BRCA1 (2010) Cancer Res, 70, pp. 532-542
• Yun, M.H., Hiom, K., Understanding the functions of BRCA1 in the DNA-damage response (2009) Biochem Soc Trans, 37, pp. 597-604
• De Luca, P., Vazquez, E.S., Moiola, C.P., Zalazar, F., Cotignola, J., Gueron, G., Gardner, K., De Siervi, A., BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer (2011) Mol Cancer Res, 9, pp. 1078-1090
• Smith, J.L., Freebern, W.J., Collins, I., De Siervi, A., Montano, I., Haggerty, C.M., McNutt, M.C., Gardner, K., Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment (2004) Proc Natl Acad Sci USA, 101, pp. 11554-11559
• De Siervi, A., De Luca, P., Moiola, C., Gueron, G., Tongbai, R., Chandramouli, G.V., Haggerty, C., Gardner, K., Identification of new Rel/NFkB regulatory networks by focused genome location analysis (2009) Cell Cycle, 8, pp. 2093-2100
• Gatei, M., Scott, S.P., Filippovitch, I., Soronika, N., Lavin, M.F., Weber, B., Khanna, K.K., Role for ATM in DNA damage-induced phosphorylation of BRCA1 (2000) Cancer Res, 60, pp. 3299-3304
• Hickson, I., Zhao, Y., Richardson, C.J., Green, S.J., Martin, N.M., Orr, A.I., Reaper, P.M., Smith, G.C., Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM (2004) Cancer Res, 64, pp. 9152-9159
• Liao, C.C., Tsai, C.Y., Chang, W.C., Lee, W.H., Wang, J.M., RB.E2F1 complex mediates DNA damage responses through transcriptional regulation of ZBRK1 (2010) J Biol Chem, 285, pp. 33134-33143
• Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A., Baer, R., The C-terminal (BRCT) domains of BRCA1 interact in vivo with Ct IP, a protein implicated in the CtBP pathway of transcriptional repression (1998) J Biol Chem, 273, pp. 25388-25392
• Zhou, B.B., Elledge, S.J., The DNA damage response: Putting checkpoints in perspective (2000) Nature, 408, pp. 433-439
• Lieberman, H.B., DNA damage repair and response proteins as targets for cancer therapy (2008) Curr Med Chem, 15, pp. 360-367
• Angèle, S., Falconer, A., Edwards, S.M., Dörk, T., Bremer, M., Moullan, N., Chapot, B., Hall, J., ATM polymorphisms as risk factors for prostate cancer development (2004) Br J Cancer, 91, pp. 783-787
• Angele, S., Falconer, A., Foster, C.S., Taniere, P., Eeles, R.A., Hall, J., ATM protein overexpression in prostate tumors: Possible role in telomere maintenance (2004) Am J Clin Pathol, 121, pp. 231-236
• Douglas, J.A., Levin, A.M., Zuhlke, K.A., Ray, A.M., Johnson, G.R., Lange, E.M., Wood, D.P., Cooney, K.A., Common variation in the BRCA1 gene and prostate cancer risk (2007) Cancer Epidemiol Biomarkers Prev, 16, pp. 1510-1516
• Gallagher, D.J., Gaudet, M.M., Pal, P., Kirchhoff, T., Balistreri, L., Vora, K., Bhatia, J., Offit, K., Germline BRCA mutations denote a clinicopathologic subset of prostate cancer (2010) Clin Cancer Res, 16, pp. 2115-2121

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------